$7.80
3.04%
Nasdaq, Aug 22, 10:00 pm CET
ISIN
US1266381052
Symbol
CVRX

CVRx Inc Stock price

$7.80
-0.27 3.35% 1M
-5.36 40.73% 6M
-4.87 38.44% YTD
-0.54 6.47% 1Y
-0.30 3.70% 3Y
-20.20 72.14% 5Y
-20.20 72.14% 10Y
-20.20 72.14% 20Y
Nasdaq, Closing price Fri, Aug 22 2025
+0.23 3.04%

Key metrics

Basic
Market capitalization
$204.0m
Enterprise Value
$158.4m
Net debt
positive
Cash
$95.0m
Shares outstanding
26.2m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
3.7 | 3.6
EV/Sales
2.9 | 2.8
EV/FCF
negative
P/B
3.5
Financial Health
Equity Ratio
53.3%
Return on Equity
-84.4%
ROCE
-46.5%
ROIC
-238.0%
Debt/Equity
0.9
Financials (TTM | estimate)
Revenue
$54.7m | $57.2m
EBITDA
$-50.4m | $-48.8m
EBIT
$-51.1m | $-52.1m
Net Income
$-52.3m | $-53.5m
Free Cash Flow
$-39.4m
Growth (TTM | estimate)
Revenue
23.1% | 11.5%
EBITDA
8.2% | 17.1%
EBIT
7.8% | 12.4%
Net Income
3.9% | 10.7%
Free Cash Flow
-3.3%
Margin (TTM | estimate)
Gross
83.5%
EBITDA
-92.2% | -85.3%
EBIT
-93.5%
Net
-95.6% | -93.6%
Free Cash Flow
-72.1%
More
EPS
$-2.0
FCF per Share
$-1.5
Short interest
10.3%
Employees
206
Rev per Employee
$250.0k
Show more

Is CVRx Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

CVRx Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a CVRx Inc forecast:

11x Buy
85%
1x Hold
8%
1x Sell
8%

Analyst Opinions

13 Analysts have issued a CVRx Inc forecast:

Buy
85%
Hold
8%
Sell
8%

Financial data from CVRx Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
55 55
23% 23%
100%
- Direct Costs 8.99 8.99
30% 30%
16%
46 46
22% 22%
84%
- Selling and Administrative Expenses 86 86
5% 5%
158%
- Research and Development Expense 10 10
4% 4%
19%
-50 -50
8% 8%
-92%
- Depreciation and Amortization 0.72 0.72
36% 36%
1%
EBIT (Operating Income) EBIT -51 -51
8% 8%
-94%
Net Profit -52 -52
4% 4%
-96%

In millions USD.

Don't miss a Thing! We will send you all news about CVRx Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

CVRx Inc Stock News

Positive
The Motley Fool
20 days ago
CVRx (CVRX) Q2 Revenue Jumps 15%
Neutral
Seeking Alpha
20 days ago
Call Start: 16:30 January 1, 0000 5:09 PM ET CVRx, Inc. (NASDAQ:CVRX ) Q2 2025 Earnings Conference Call August 04, 2025, 04:30 PM ET Company Participants Jared Oasheim - Chief Financial Officer Kevin Hykes - President, CEO & Director Conference Call Participants Brandon Vazquez - William Blair & Company L.L.C., Research Division Chase Richard Knickerbocker - Craig-Hallum Capital Group LLC, Rese...
Neutral
GlobeNewsWire
20 days ago
MINNEAPOLIS, Aug. 04, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced its financial and operating results for the second quarter of 2025.
More CVRx Inc News

Company Profile

CVRx, Inc. develops proprietary active implantable technology to treat high blood pressure and heart failure. It has developed the second generation Barostim neo, an implantable system designed to treat heart failure and hypertension. It operates through the following geographical segments: United States, Germany, and Other Countries. The company was founded by Robert S. Kieval and Tyler P. Lipschultz in August 2000 and is headquartered in Minneapolis, MN.

Head office United States
CEO Kevin Hykes
Employees 206
Founded 2001
Website www.cvrx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today